{"nct_id":"NCT06625320","title":"Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)","status":"RECRUITING","status_verified_date":"2024-10","start_date":"2024-10-16","start_date_type":"ACTUAL","primary_completion_date":"2026-06","primary_completion_date_type":"ESTIMATED","completion_date":"2027-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["RVMD"]}